Latest insights

Real Estate Private Debt: Time to Act?

Fabrice Sauzeau, Absolute Return, Fixed Income, Private Debt, Research Paper, Real Estate
Has commercial real estate reached its inflection point? With little transaction activity, price and index data are generated with a lag. Market prices can change much more rapidly than they can be aggregated and reported. Investors must rely on fundamental analysis and experience more than data to time the recovery.
7 results found
  • Oncology
Show me
  • Topic
  • Theme
  • Publication
  • Author
Show me
  • Topic
  • Theme
  • Publication
from
  • Author
7 results found
  • Oncology
Malgorzata Kluba, Rudi Van Den Eynde, Oncology, Equities

World Cancer Day 2023

And we would rather not have to go through this – which would mean we won the battle and cancer is curable.
Oncology, Q&A, Rudi Van Den Eynde, Equities

Investing in oncology: forewarned is forearmed

Rudi Van Den Eynde, Head of Thematic Global Equity at Candriam, explains to investors the approach he used to create and develop an investment strategy in the oncology sector.
Oncology

World Cancer Day: How PRISM is helping to Close the Gap

The Candriam Institute provides financial support to the PRecISion Medicine Institute. The PRISM technology aims to save an additional 200,000 lives each year by identifying the unique molecular characteristics of each patient's cancer.
Oncology, ESG, SRI

World Cancer Day: How PRISM is helping to Close the Gap

The Candriam Institute provides financial support to the PRecISion Medicine Institute. The PRISM technology aims to save an additional 200,000 lives each year by identifying the unique molecular characteristics of each patient's cancer. With this information, more targeted treatment can be applied at each step, improving survival rates.
Oncology

Fight against cancer: Let’s write another story together

While cancer is still striking hard and remains among the leading causes of death globally, pharmaceutical innovation is continuing at a high pace. The patients’ survival rate keeps increasing, as is our understanding of the disease and its multiple forms deepens, and as breakthrough therapies are tested and launched. 

Find it fast

Get information faster with a single click

Get insights straight to your inbox